Maximillian F Konig

45PUBLICATIONS
164CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Mar 16, 2026
Lethal toxin-equipped effector cells for the potential treatment of cancer.

Alexander H Pearlman, Brian J Mog, Michael S Hwang

|Feb 10, 2026
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

Amanda L Huff, S Daniel Haldar, Alexander A Gergis

|Dec 22, 2025
TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers.

Jiaxin Ge, Joshua Urban, Sarah R DiNapoli

|Aug 25, 2025
Detection of Human Brain Cancers using Genomic and Immune Cell Characterization of Cerebrospinal Fluid through CSF-BAM.

Alexander H Pearlman, Yuxuan Wang, Anita Kalluri

|Aug 20, 2025
Fragmentation signatures in cancer patients resemble those of patients with vascular or autoimmune diseases.

Samuel D Curtis, Tingshan Liu, Yuxin Bai

Pageof 8